Nilotinib Interferes With Cell Cycle, ABC Transporters and JAK-STAT Signaling Pathway in CD34+/lin- Cells of Patients With Chronic Phase Chronic Myeloid Leukemia After 12 Months of Treatment

PLoS ONE - United States
doi 10.1371/journal.pone.0218444